课题基金 / 基金详情

The impact of price-caps on the generic pharmaceutical industry and provincial drug plan costs in Canada

The impact of price-caps on the generic pharmaceutical industry and provincial drug plan costs in Canada
价格上限对加拿大仿制药行业和省级药物计划成本的影响
批准号：
238754
负责人：
Anis Aslam H
金额：
$8.4万
依托单位：
St. Paul's Hospital, Vancouver
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-09-01 至 2013-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=238754&lang=en
关键词：
Competition Generic Drugs Health Economics Health Policy Patent Protection Pharmaceutical Policy Pharmaceuticals Price

项目摘要

项目成果

Anis Aslam H的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Since 2010, several provincial governments in Canada have announced reductions in the maximum price of generic drugs, setting new price caps as a percentage of the price of the branded drug product. Despite their popularity, evidence suggests that price c
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating and Informing Canada's Proposed Pharmaceutical Price Regulations
CIHR Clinical Trials Network in HIV/AIDS
  • 批准号：
    392040
  • 项目类别：
    Directed Grant
  • 资助金额：
    $1664.62万
  • 财政年份：
    2018
  • 负责人：
    Anis Aslam H
  • 依托单位：
    St. Paul's Hospital, Vancouver
Sharing the CIHR Canadian HIV Trials Network's Experience With Community-Investigator Collaborations: AIDS 2018 - Amsterdam, Netherlands
  • 批准号：
    383703
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $1.45万
  • 财政年份：
    2018
  • 负责人：
    Anis Aslam H
  • 依托单位：
    University of British Columbia
The pricing of generic drugs and its impact on market structure, competitiveness and security of supply
海外基金